Non-bacterial thrombotic endocarditis historical perspective
|
non-bacterial thrombotic endocarditis |
|
Differentiating non-bacterial thrombotic endocarditis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non-bacterial thrombotic endocarditis historical perspective On the Web |
|
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis historical perspective |
|
FDA on Non-bacterial thrombotic endocarditis historical perspective |
|
CDC on Non-bacterial thrombotic endocarditis historical perspective |
|
Non-bacterial thrombotic endocarditis historical perspective in the news |
|
Blogs on Non-bacterial thrombotic endocarditis historical perspective |
|
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Overview
Historical Perspective
Discovery
- The association between thromboembotic events and malignancy was made by Armand Trousseau in the year 1865.[1]
- Non-bacterial thrombotic endocarditis (NBTE) was first discovered by Zeigler,[2] in 1888 following his identification of vegetation in cardiac valves associated with inflammatory states.
- In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman[3] published cases of "valvular masses" that were examined clinically and during autopsies and found to be free of all microorganisms. These masses were initially named "indeterminate endocarditis".
- In 1936, The name non-bacterial thrombotic endocarditis was coined by Gross and Friedberg. [4]. They postulated that the attachment of fibrin to cardiac valves is the cause of non-bacterial thrombotic endocarditis.
- In recent years it has been suggested that NBTE is a hypercoagulable state caused by a malignancy that leads to a surge in tumor necrosis factor and interleukin-1, resulting in the formation of thrombi.[5]
- More recently, in addition to malignancies, NBTEs have been associated with infectious and autoimmune diseases and more recently, sepsis and burns.[6][7][8]
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Famous Cases
The following are a few famous cases of [disease name]:
References
- ↑ Trousseau A. Clinique médicale de l’Hôtel-Dieu de Paris. Paris: Ballière; 1865
- ↑ Lopez JA, Ross RS, Fishbein MC, Siegel RJ (March 1987). "Nonbacterial thrombotic endocarditis: a review". Am. Heart J. 113 (3): 773–84. doi:10.1016/0002-8703(87)90719-8. PMID 3548296.
- ↑ E Ziegler - Ver Kong Inn Med, 1888 - ci.nii.ac.jp
- ↑ GROSS L, FRIEDBERG CK. NONBACTERIAL THROMBOTIC ENDOCARDITIS: CLASSIFICATION AND GENERAL DESCRIPTION. Arch Intern Med (Chic). 1936;58(4):620–640. doi:10.1001/archinte.1936.00170140045004
- ↑ Schlittler LA, Dallagasperina VW, Schavinski C, Baggio AP, Lazaretti NS, Villaroel RU. Marantic endocarditis and adenocarcinoma of unknown primary site. Arq Bras Cardiol. 2011;96(4):e73–5
- ↑ Wada H, Sase T, Yamaguchi M (September 2005). "Hypercoagulant states in malignant lymphoma". Exp. Oncol. 27 (3): 179–85. PMID 16244577.
- ↑ Ferrans VJ, Rodríguez ER (1985). "Cardiovascular lesions in collagen-vascular diseases". Heart Vessels Suppl. 1: 256–61. doi:10.1007/BF02072405. PMID 3916476.
- ↑ Deppisch LM, Fayemi AO (December 1976). "Non-bacterial thrombotic endocarditis: clinicopathologic correlations". Am. Heart J. 92 (6): 723–9. doi:10.1016/s0002-8703(76)80008-7. PMID 998478.